Stem cell research and cell transplantation for myocardial regeneration

Siepe, Matthias; Heilmann, Claudia; von Samson, Patrick; Menasché, Philippe; Beyersdorf, Friedhelm
August 2005
European Journal of Cardio-Thoracic Surgery;Aug2005, Vol. 28 Issue 2, p318
Academic Journal
Summary: Several human organs are not capable of functional regeneration following a tissue defect and react with scar formation. In stem cell transplantation, undifferentiated or partly differentiated precursor cells are applied to defective tissue for therapeutic regeneration. After promising preclinical investigations, the transplantation of autologous stem cells for myocardial infarction treatment is being transferred to clinical use. Mesenchymal stem cells and endothelial precursor cells derived from the bone marrow or circulating blood as well as skeletal myoblasts are employed in clinical trials. Furthermore, indications for cell transplantation and delivery routes vary considerably throughout current investigations. Initial results suggest a potential for restoration of cardiac function in stem cell-treated patients; however, the mechanisms are not fully understood. This overview will focus on objectives, recent achievements, and future perspectives of diverse stem cell transplantation approaches.


Related Articles

  • Could a Dose of Stem Cells Heal a Failing Heart? Baldauf, Sarah // U.S. News & World Report;Dec2009, Vol. 146 Issue 11, p59 

    The article discusses the clinical trial that utilizes an adult's own stem cells to regenerate heart muscle and improve blood flow in patients with heart failure. The author reports that there are unanswered questions regarding stem cell use in heart failure including how to deliver stem cells...

  • Cell therapy in the heart. Abdelli, Latifa S.; Merino, Hilda; Rocher, Crystal M.; Singla, Dinender K. // Canadian Journal of Physiology & Pharmacology;Mar2012, Vol. 90 Issue 3, p307 

    Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many experimental and clinical studies investigating the transplantation of cells into the injured myocardium have yielded promising results. Moreover, data from these reports show that transplanted...

  • Donor stem cells explored in post-heart attack therapy.  // Cardiovascular Devices & Drugs;May2008, Vol. 14 Issue 5, p34 

    The article focuses on a study which found that a type of stem cell promotes better healing in heart attack patients while also acting to stave off congestive heart failure (CHF) which could be developed by patients following a heart attack. The stem cells used in this study are known as...

  • Research Highlights.  // Molecular Therapy;Jun2013, Vol. 21 Issue 6, p1107 

    This section offers information on research studies on molecular therapy that are published in scientific jouirnals. A three-dimensional (3D) human heart muscle similar to native human heart tissue was grown by biomedical engineers. Growth Differentiation Factor 11 (GDF-11) protein was...

  • Short-term mechanical stretch fails to differentiate human adipose-derived stem cells into cardiovascular cell phenotypes. Girão-Silva, Thais; Bassaneze, Vinicius; Gastalho Campos, Luciene Cristina; Garrone Barauna, Valerio; Oliveira Dallan, Luis Alberto; Krieger, Jose Eduardo; Miyakawa, Ayumi Aurea // BioMedical Engineering OnLine;2014, Vol. 13 Issue 1, p1 

    Background We and others have previously demonstrated that adipose-derived stem cells (ASCs) transplantation improve cardiac dysfunction post-myocardium infarction (MI) under hemodynamic stress in rats. The beneficial effects appear to be associated with pleiotropic factors due to a complex...

  • Attempts to Recruit Stem Cells for Repair of Acute Myocardial Infarction. Kloner, Robert A. // JAMA: Journal of the American Medical Association;3/1/2006, Vol. 295 Issue 9, p1058 

    The article reflects on treatments of acute myocardial infarction (AMI) and attempts to recruit adult stem cells to repair the infarction. The author looks at the possibility of treating AMI by implanting immature cells like neonatal or fetal cardiomyocytes into myocardium. However, with the low...

  • Scientists Use Modified Stem Cells to Rejuvenate Aging Heart Tissue. Dutt, Ela // News India Times;08/03/2012, Vol. 43 Issue 31, p6 

    The article reports on a research led by Sadia Mohsin, a post-doctoral scholar at the San Diego State University's Hearth Institute, who uses modified stem cells to rejuvenate damaged and aged heart failure.

  • Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection. Noguchi, H; Saitoh, I; Tsugata, T; Kataoka, H; Watanabe, M; Noguchi, Y // Cell Death & Differentiation;Jan2015, Vol. 22 Issue 1, p145 

    Although induced pluripotent stem (iPS) cells have significant implications for overcoming most of the ethical issues associated with embryonic stem (ES) cells, there are still several unresolved issues related to the use of iPS cells for clinical applications, such as teratoma formation. In...

  • Cell Based Approaches for Myocardial Regeneration and Artificial Myocardium. Genovese, Jorge; Cortes-Morichetti, Miguel; Chachques, Emmanuel; Frati, Giacomo; Patel, Amit; Chachques, Juan C. // Current Stem Cell Research & Therapy;May2007, Vol. 2 Issue 2, p121 

    Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics